Skip to main content
. Author manuscript; available in PMC: 2009 May 4.
Published in final edited form as: Reprod Sci. 2008 Jan 9;15(4):374–381. doi: 10.1177/1933719107311780

Table 3.

Risk of Preterm Delivery and SGA With Elevated cFN and Hyperuricemia

Risk of Preterm Delivery (<37 wk) Risk of SGA (<10th Centile)


Group n Unadjusted Prevalence Adjusted ORa 95% CI Unadjusted Prevalence Adjusted ORa 95% CI
Normotensive N 316 7.9 1.0 Referent 7.0 1.0 Referent
Elevated cFN C 102 2.9 0.3 0.1-1.1 11.5 1.7 0.8-3.4
Hyperuricemia U 126 5.6 0.6 0.3-1.4 8.7 1.1 0.5-2.3
Hyperuricemia and elevated cFN UC 61 9.8 1.2 0.5-2.9 4.9 0.8 0.2-2.6
Hypertension only H 83 3.6 0.4 0.1-1.3 10.8 1.3 0.6-3.3
Hypertension and elevated cFN HC 21 9.5 1.0 0.2-4.4 9.5 1.3 0.3-6.1
Hypertension and hyperuricemia HU 36 22.2 3.1 1.3-7.5 19.4 3.4 1.3-8.7
Hypertension, hyperuricemia, elevated cFN HUC 31 16.1 2.0 0.7-5.6 19.4 2.7 0.9-7.8
Preeclampsia HP 37 10.8 1.3 0.4-3.9 16.2 2.0 0.7-5.8
Preeclampsia and elevated cFN HPC 28 13.8 1.7 0.5-5.2 13.8 2.7 0.9-8.6
Preeclampsia and hyperuricemia HPU 42 42.9 8.0 3.8-16.4 16.7 2.7 1.1-6.7
Preeclampsia, hyperuricemia, and elevated cFN HPUC 80 58.2 14.7 8.1-26.7 30.4 6.8 3.5-13.1

Abbreviations: cFN, cellular fibronectin; CI, confidence interval; OR, odds ratio; SGA, small for gestational age.

a

Adjusted for prepregnancy body mass index and smoking.